Jazz Pharmaceuticals to Participate in the 2023 RBC Capital Markets Global Healthcare Conference
DUBLIN, May 2, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the…
117,925€
-0,46%
Echtzeit-Aktienkurs Jazz Pharmaceuticals plc
Bid:
Ask:
Nachrichten zur Jazz Pharmaceuticals plc Aktie
Jazz Pharmaceuticals to Report 2023 First Quarter Financial Results on May 10, 2023
DUBLIN, April 26, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 first…
Freedom Finance Börsenfrühstück - "Milliardenmarkt Krebsforschung und Krebstherapie"
Es sind erschreckende Zahlen: Eine halbe Million Menschen erkrankt in Deutschland jedes Jahr an Krebs. Meist beginnt damit ein Leidensweg…
Insiderhandel: EVP, GM of U.S., Commercial Ma verkauft Aktien von Jazz Pharmaceuticals im Wert von 421.044$
Sablich, Kim - Vorstand - Tag der Transaktion: 2023-03-08...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Jazz Pharmaceuticals im Wert von 372.267$
Okeefe, Kenneth W. - Aufsichtsrat - Tag der Transaktion: 2023-03-07...…
Insiderhandel: SVP, Technical Operations verkauft Aktien von Jazz Pharmaceuticals im Wert von 292.081$
Larkin, Finbar - Vorstand - Tag der Transaktion: 2023-03-07...…
Insiderhandel: SVP, Chief Accounting Officer verkauft Aktien von Jazz Pharmaceuticals im Wert von 161.594$
Carr, Patricia - Vorstand - Tag der Transaktion: 2023-03-05...…
Insiderhandel: SVP, Technical Operations verkauft Aktien von Jazz Pharmaceuticals im Wert von 245.526$
Larkin, Finbar - Vorstand - Tag der Transaktion: 2023-03-06...…
Jazz Pharmaceuticals (JAZZ) Reports Q4 Loss, Misses Revenue Estimates
Jazz (JAZZ) delivered earnings and revenue surprises of -113.73% and 0.06%, respectively, for the quarter ended December 2022. Do the…
Jazz Pharma Q4 2022 results are a miss, but 2023 outlook hits a high note; stock up 5%
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Jazz Pharmaceuticals Non-GAAP EPS of -$0.07 misses by $1.19, revenue of $972.12M misses by $3.75M, guidance in-line
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2022 Financial Results and Provides 2023 Financial Guidance
Strong Execution Drove Record Revenues in 2022 of $3.7 billion, an increase of 18% over 2021 Positioned for Total Revenue…
Form 8-K Jazz Pharmaceuticals For: Mar 01
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Earnings Preview For Jazz Pharmaceuticals
read more...…
Why Earnings Season Could Be Great for Jazz Pharmaceuticals (JAZZ)
Jazz Pharmaceuticals (JAZZ) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings…
A Drug Company Exploited a Safety Requirement to Make Money
With a history as a date rape drug, a medication needed strict distribution controls. Its maker, Jazz Pharmaceuticals, used that…
UPDATE 2-Jazz Pharma ruling clears U.S. roadblock for rival narcolepsy drug
...(Adds comment from Avadel)
By Blake Brittain
Feb 24 (Reuters) - A U.S......…
Jazz Pharma ruling clears U.S. roadblock for rival narcolepsy drug
...By Blake Brittain
(Reuters) - A U.S. appeals court ordered Jazz......…
Analysts Estimate Jazz Pharmaceuticals (JAZZ) to Report a Decline in Earnings: What to Look Out for
Jazz (JAZZ) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Jazz Pharmaceuticals to Report 2022 Fourth Quarter and Full Year Financial Results on March 1, 2023
DUBLIN, Feb. 15, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2022 fourth…
Insiderhandel: Chairman & CEO verkauft Aktien von Jazz Pharmaceuticals im Wert von 155.790$
Cozadd, Bruce C. - Vorstand - Tag der Transaktion: 2023-02-01...…
Jazz Pharma, Zymeworks post 84% overall survival for GIT cancer candidate
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Zymeworks shares gain on promising data for cancer drug in development with Jazz Pharmaceuticals
Shares of Zymeworks Inc. ZYME rallied 14% in premarket trading on Thursday after the company and Jazz Pharmaceuticals Inc. JAZZ…
Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating Zanidatamab in HER2-Expressing Metastatic Gastroesophageal Adenocarcinoma
Results presented today at ASCO GI include first overall survival (OS) data for zanidatamab, overall confirmed objective response rate (cORR)…
Form 8-K Jazz Pharmaceuticals For: Jan 09
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: SVP, Head of Europe & Internat verkauft Aktien von Jazz Pharmaceuticals im Wert von 84.742$
Pearce, Samantha - Vorstand - Tag der Transaktion: 2023-01-03...…
Insiderhandel: Chairman & CEO verkauft Aktien von Jazz Pharmaceuticals im Wert von 479.590$
Cozadd, Bruce C. - Vorstand - Tag der Transaktion: 2023-01-03...…
Jazz Pharma files patent infringement suit against Teva, Taro over generic Epidiolex
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Jazz Pharmaceuticals For: Jan 03
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Jazz Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
DUBLIN, Jan. 3, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate…
Hikma Pharma Launches Authorized Generic Version Of Xyrem In U.S.
LONDON (dpa-AFX) - Hikma Pharmaceuticals PLC said that it has launched an authorized generic version of Jazz Pharmaceuticals Xyrem (sodium…